UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Tumor Angiogenesis

The New England journal of medicine, 2008-05, Vol.358 (19), p.2039-2049

Kerbel, Robert S

2008

Volltextzugriff (PDF)

Pharmacokinetics of metronomic chemotherapy: a neglected but crucial aspect

Nature reviews. Clinical oncology, 2016-11, Vol.13 (11), p.659-673

2016

Volltextzugriff (PDF)

Antiangiogenic Therapy: A Universal Chemosensitization Strategy for Cancer?

Science (American Association for the Advancement of Science), 2006-05, Vol.312 (5777), p.1171-1175

Kerbel, Robert S

2006

Volltextzugriff (PDF)

Mouse models of advanced spontaneous metastasis for experimental therapeutics

Nature reviews. Cancer, 2011-02, Vol.11 (2), p.135-141

2011

Volltextzugriff (PDF)

A Decade of Experience in Developing Preclinical Models of Advanced- or Early-Stage Spontaneous Metastasis to Study Antiangiogenic Drugs, Metronomic Chemotherapy, and the Tumor Microenvironment

The cancer journal (Sudbury, Mass.), 2015-07, Vol.21 (4), p.274-283

Kerbel, Robert S

2015

Volltextzugriff (PDF)

Antiangiogenic therapy: impact on invasion, disease progression, and metastasis

Nature reviews. Clinical oncology, 2011-04, Vol.8 (4), p.210-221

2011

Volltextzugriff (PDF)

Endothelial expression of autocrine VEGF upon the uptake of tumor-derived microvesicles containing oncogenic EGFR

Proceedings of the National Academy of Sciences - PNAS, 2009-03, Vol.106 (10), p.3794-3799

2009

Volltextzugriff (PDF)

The anti-angiogenic basis of metronomic chemotherapy

Nature reviews. Cancer, 2004-06, Vol.4 (6), p.423-436

2004

Volltextzugriff (PDF)

The multifaceted circulating endothelial cell in cancer: towards marker and target identification

Nature reviews. Cancer, 2006-11, Vol.6 (11), p.835-845

2006

Volltextzugriff (PDF)

miR-30b/30d Regulation of GalNAc Transferases Enhances Invasion and Immunosuppression during Metastasis

Cancer cell, 2011-07, Vol.20 (1), p.104-118

2011

Volltextzugriff (PDF)

Vessel co‐option is common in human lung metastases and mediates resistance to anti‐angiogenic therapy in preclinical lung metastasis models

The Journal of pathology, 2017-02, Vol.241 (3), p.362-374

2017

Volltextzugriff (PDF)

Tumor and Host-Mediated Pathways of Resistance and Disease Progression in Response to Antiangiogenic Therapy

Clinical cancer research, 2009-08, Vol.15 (16), p.5020-5025

2009

Volltextzugriff (PDF)

Effects of Sorafenib Dose on Acquired Reversible Resistance and Toxicity in Hepatocellular Carcinoma

Cancer research (Chicago, Ill.), 2015-06, Vol.75 (12), p.2510-2519

2015

Volltextzugriff (PDF)

Glioma Tumor Stem-Like Cells Promote Tumor Angiogenesis and Vasculogenesis via Vascular Endothelial Growth Factor and Stromal-Derived Factor 1

Cancer research (Chicago, Ill.), 2009-09, Vol.69 (18), p.7243-7251

2009

Volltextzugriff (PDF)

Anticancer therapies combining antiangiogenic and tumor cell cytotoxic effects reduce the tumor stem-like cell fraction in glioma xenograft tumors

Cancer research (Chicago, Ill.), 2007-04, Vol.67 (8), p.3560-3564

2007

Volltextzugriff (PDF)

A new Tie1 targeted antibody blocks tumor cell extravasation and metastasis

EMBO molecular medicine, 2020-06, Vol.12 (6), p.e12355-n/a

2020

Volltextzugriff (PDF)

Metronomic oral topotecan prolongs survival and reduces liver metastasis in improved preclinical orthotopic and adjuvant therapy colon cancer models

Gut, 2013-02, Vol.62 (2), p.259-271

2013

Volltextzugriff (PDF)

Pre- and post-operative anti-PD-L1 plus anti-angiogenic therapies in mouse breast or renal cancer models of micro- or macro-metastatic disease

British journal of cancer, 2019-01, Vol.120 (2), p.196-206

2019

Volltextzugriff (PDF)

Metronomic chemotherapy offsets HIFα induction upon maximum‐tolerated dose in metastatic cancers

EMBO molecular medicine, 2020-09, Vol.12 (9), p.e11416-n/a

2020

Volltextzugriff (PDF)

Development of Patient Derived Xenograft Models of Overt Spontaneous Breast Cancer Metastasis: A Cautionary Note

PloS one, 2016-06, Vol.11 (6), p.e0158034-e0158034

2016

Volltextzugriff (PDF)

Multiple circulating proangiogenic factors induced by sunitinib malate are tumor-independent and correlate with antitumor efficacy

Proceedings of the National Academy of Sciences - PNAS, 2007-10, Vol.104 (43), p.17069-17074

2007

Volltextzugriff (PDF)

Potent efficacy of metronomic topotecan and pazopanib combination therapy in preclinical models of primary or late stage metastatic triple-negative breast cancer

Oncotarget, 2015-12, Vol.6 (40), p.42396-42410

2015

Volltextzugriff (PDF)

Therapy-Induced Acute Recruitment of Circulating Endothelial Progenitor Cells to Tumors

Science (American Association for the Advancement of Science), 2006-09, Vol.313 (5794), p.1785-1787

2006

Volltextzugriff (PDF)

Antiangiogenic strategies on defense : On the possibility of blocking rebounds by the tumor vasculature after chemotherapy

Cancer research (Chicago, Ill.), 2007-08, Vol.67 (15), p.7055-7058

2007

Volltextzugriff (PDF)

Improving immunotherapy outcomes with anti-angiogenic treatments and vice versa

Nature reviews. Clinical oncology, 2018-05, Vol.15 (5), p.310-324

2018

Volltextzugriff (PDF)

1 – 25 von 464

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(445)
Mit Volltextzugriff
(427)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Tumor Angiogenesis

Pharmacokinetics of metronomic chemotherapy: a neglected but crucial aspect

Antiangiogenic Therapy: A Universal Chemosensitization Strategy for Cancer?

Mouse models of advanced spontaneous metastasis for experimental therapeutics

A Decade of Experience in Developing Preclinical Models of Advanced- or Early-Stage Spontaneous Metastasis to Study Antiangiogenic Drugs, Metronomic Chemotherapy, and the Tumor Microenvironment

Antiangiogenic therapy: impact on invasion, disease progression, and metastasis

Endothelial expression of autocrine VEGF upon the uptake of tumor-derived microvesicles containing oncogenic EGFR

The anti-angiogenic basis of metronomic chemotherapy

The multifaceted circulating endothelial cell in cancer: towards marker and target identification

miR-30b/30d Regulation of GalNAc Transferases Enhances Invasion and Immunosuppression during Metastasis

Vessel co‐option is common in human lung metastases and mediates resistance to anti‐angiogenic therapy in preclinical lung metastasis models

Tumor and Host-Mediated Pathways of Resistance and Disease Progression in Response to Antiangiogenic Therapy

Effects of Sorafenib Dose on Acquired Reversible Resistance and Toxicity in Hepatocellular Carcinoma

Glioma Tumor Stem-Like Cells Promote Tumor Angiogenesis and Vasculogenesis via Vascular Endothelial Growth Factor and Stromal-Derived Factor 1

Anticancer therapies combining antiangiogenic and tumor cell cytotoxic effects reduce the tumor stem-like cell fraction in glioma xenograft tumors

A new Tie1 targeted antibody blocks tumor cell extravasation and metastasis

Metronomic oral topotecan prolongs survival and reduces liver metastasis in improved preclinical orthotopic and adjuvant therapy colon cancer models

Pre- and post-operative anti-PD-L1 plus anti-angiogenic therapies in mouse breast or renal cancer models of micro- or macro-metastatic disease

Metronomic chemotherapy offsets HIFα induction upon maximum‐tolerated dose in metastatic cancers

Development of Patient Derived Xenograft Models of Overt Spontaneous Breast Cancer Metastasis: A Cautionary Note

Multiple circulating proangiogenic factors induced by sunitinib malate are tumor-independent and correlate with antitumor efficacy

Potent efficacy of metronomic topotecan and pazopanib combination therapy in preclinical models of primary or late stage metastatic triple-negative breast cancer

Therapy-Induced Acute Recruitment of Circulating Endothelial Progenitor Cells to Tumors

Antiangiogenic strategies on defense : On the possibility of blocking rebounds by the tumor vasculature after chemotherapy

Improving immunotherapy outcomes with anti-angiogenic treatments and vice versa

Suchergebnisse filtern